A solvent-suppressed NMR method quantifies rotigotine, mannitol, and stearic acid in microspheres, indicating efficient formulation monitoring.
We developed a solvent-suppressed 1H nuclear magnetic resonance (NMR) method for the quantitative analysis of the components of rotigotine prolonged-release microspheres prepared for injection. Dimethyl terephthalate was used as an internal standard and dimethylsulfoxide -d6 as the solvent. The analysis was performed using a Bruker Avance III HD 600 MHz NMR spectrometer, employing the noesygppr1d pulse sequence at a controlled temperature of 25 °C. Nuclear magnetic resonance spectra were acquired with a relaxation delay time (D1) of 40 s to simultaneously determine the content of rotigotine and the excipients mannitol and stearic acid in the rotigotine prolonged-release microspheres. Using the proposed approach, we successfully quantified the active pharmaceutical ingredient rotigotine and excipients in the prolonged-release microspheres. This method demonstrated excellent linearity, high precision, and strong repeatability. The solvent-suppressed 1H NMR method developed in this study allows for the simultaneous quantification of rotigotine and the key excipients mannitol and stearic acid in the prolonged-release microspheres. This approach is accurate, simple, efficient, and environmentally friendly.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: